A Risk Sciences International Case Study

Systematic Review of Artificial Sweeteners and Health Risks

Artificial sweeteners

Client: International Prevention Research Institute (IPRI)

Listing of the client in no way affirms the client's support, sponsorship, or validation in any form of Risk Sciences International or the RSI staff member(s) who conducted this project during their stay with RSI or prior to joining the company. This case study is displayed for informative purposes only to demonstrate the capacity of RSI staff members. This case study reveals no proprietary information or information deemed sensitive.

Project description:

Systematic Review of Artificial Sweeteners and Health Risks

A comprehensive systematic review was undertaken to assess experimental evidence regarding the potential health risks associated with artificial sweeteners, specifically focusing on cancer and pre-term delivery. The client sought a rigorous analysis of both in vivo and in vitro experimental studies to better understand any biological associations or mechanisms that might underpin observed health outcomes.

To meet these objectives, a structured literature search was conducted across multiple scientific databases to identify relevant experimental and observational studies. Studies were screened and assessed for quality and relevance, with a particular focus on artificial sweeteners such as saccharin, cyclamates, aspartame, stevia, and others. Data extraction and synthesis were performed to evaluate carcinogenicity, genotoxicity, and reproductive toxicity, including gestation length.

The resulting analysis explored whether artificial sweeteners could be linked to increased cancer risk or early delivery across mammalian models and cellular systems. The review also examined mechanisms of action, such as DNA damage, cell proliferation, and other biochemical endpoints. Findings were contextualized within existing scientific committee evaluations to assess the implications for human health risk assessments.
This work, conducted on behalf of the International Prevention Research Institute, was commissioned to support the scientific evidence needs of The Coca-Cola Company in relation to the safety profile of low- and no-calorie sweeteners.

Start: 2014

End: 2014

Experts related to this case study

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

Nataliya Karyakina

Senior Toxicologist, Health Risk Analyst

Dr. Nataliya Karyakina is a Senior Toxicologist and Health Risk Analyst at Risk Sciences International (RSI), where she has served since 2008. She plays a central role in RSI’s work at the intersection of chemical safety, regulatory science, and human...
Read More about Nataliya Karyakina

Natalia (Natasha) Shilnikova

Senior Health Risk Analyst

Dr. Natalia (Natasha) Shilnikova is a Senior Health Risk Analyst at Risk Sciences International (RSI), where she has contributed since 2011 to some of the organization’s most analytically demanding and policy-relevant projects. With a background in medicine and a PhD...
Read More about Natalia (Natasha) Shilnikova

More RSI Case Studies

RSI presents a very small selection of case studies to highlight some of its key work.

External Peer Consultation of the Inorganic – Late Biomonitoring Approach Draft Screening Assessment Report

To support the Chemicals Management Plan under the Canadian Environmental Protection Act (CEPA), Health Canada sought expert peer consultation for a draft screening assessment report (DSAR) evaluating 47 inorganic substances identified as priorities. The client required independent scientific and technical...
Read More about External Peer Consultation of the Inorganic – Late Biomonitoring Approach Draft Screening Assessment Report

Risk Communication on McIntyre Powder

In response to increasing public concern about the historical use of McIntyre Powder—an aluminum-based substance once administered to miners in Ontario to prevent silicosis—the client sought expert guidance on managing risk communication related to potential health implications. Widespread media coverage...
Read More about Risk Communication on McIntyre Powder

Analysis in Support of Risk-Based Decision-Making for the Alberta Safety Codes Council

An independent regulatory organization responsible for oversight of Alberta’s safety codes system sought to strengthen its capacity for risk-based decision-making. The organization aimed to ensure that regulatory actions—particularly in the area of petroleum storage tanks—were guided by clear, evidence-based prioritization...
Read More about Analysis in Support of Risk-Based Decision-Making for the Alberta Safety Codes Council

Update of WHO Guidance on Food Defense

To support international efforts in mitigating deliberate threats to the food system, the World Health Organization commissioned an update to its earlier guidance titled Terrorist Threats to Food. The revision aimed to broaden the original scope by addressing not only...
Read More about Update of WHO Guidance on Food Defense

Evaluation of Health Product Risk Communication Tools

To enhance the effectiveness of health product risk communications, a systematic evaluation was requested to assess the performance of key instruments used to disseminate safety and efficacy information. The aim was to support efforts under the Evaluating the Effectiveness of...
Read More about Evaluation of Health Product Risk Communication Tools

Evaluation of Drug Recall Communication and Risk Determination Processes

In response to public and ministerial concerns about the timeliness and adequacy of information shared during a major prescription drug recall, Health Canada commissioned an independent review to assess its response to the event. The situation involved a recall of...
Read More about Evaluation of Drug Recall Communication and Risk Determination Processes

Expansion of the Stochastic Health Canada Quantitative Microbial Risk Assessment Tool

Health Canada sought to enhance its Quantitative Microbial Risk Assessment (QMRA) tool, originally developed over 15 years ago for stakeholders responsible for drinking water systems. With advancements in probabilistic modeling and microbial risk assessment, the client required updates to reflect...
Read More about Expansion of the Stochastic Health Canada Quantitative Microbial Risk Assessment Tool